About: Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.87 (-2.50%)
PHIO NASDAQ Phio Pharmaceuticals Corp
Phio Pharmaceuticals Corp share price
Atividade de preço de PHIO
Último preço
$ 0,870
Variação (24h)
-0,02 USD (2,50%)
Volume
53.58K
Volume (média 4 sem.)
-
Abertura
$ 0,90
Variação do dia
$ 0,87 - $ 0,91
Fechamento anterior
$ 0,89
Último negócio
22 Oct, 8:00 pm GMT+0
Atrasado
22 Oct, 8:00 pm GMT+0
PHIO price performance
Atrasado
22 Oct, 8:00 pm GMT+0
quote.marketSignals